Announcements

Opyl Full Year FY22 Results Announcement

Opyl partners with leading patient advocate groups

Opyl signs two clinical trial recruitment contracts

Opyl receives $361K R&D tax refund

Opyl Director Mr Basyrov steps down

Notice of 2021 Annual General Meeting

Opyl to present at next week’s IRD Invest

Port Jackson Securities Webinar

Investor webinar: Full year results and update on Opin, the company’s recently launched clinical trial recruitment platform

Opyl’s clinical trial recruitment platform Opin enters global strategic alliance

Opyl appoints Dr Megan Robertson to its Board

Opyl completes unmarketable parcel share buy-back